Ulf Holmbäck
Associerad forskare vid Institutionen för folkhälso- och vårdvetenskap; Klinisk nutrition och metabolism
- Mobiltelefon:
- 070-173 00 41
- E-post:
- ulf.holmback@uu.se
- Besöksadress:
- Husargatan 3, BMC
751 22 Uppsala - Postadress:
- Husargatan 3, BMC, Box 564
751 22 UPPSALA
- Akademiska meriter:
- Docent
Kort presentation
Jag är docent i klinisk nutrition och metabolism samt pedagogisk utvecklare. Mitt nuvarande huvudsakliga forskningsområde är klinisk behandling av obesitas. Jag påbörjade min undervisningskarriär i mitten av 1990-talet, där jag har undervisat i nutrition inom den medicinska fakulteten. Jag har tidigare arbetat vid enheten för universitetspedagogik samt i MedFarms pedagogiska forskningsråd (PRåM). Vidare var jag medlem i Mentorskollegiet (se mer nedan).
Nyckelord
- obesitas
- alternativkoster
- dygnsrytm
- e-lärande
- undervisningsformer
Biografi
Jag var medlem i mentorsnätverket (som upphörde 2024) för att jag tyckte det är är stimulerande och intressant att diskutera och fundera kring undervisning och undervisningsformer.
Jag har under åren testat eller sett andra testa olika undervisningsformer, och tycker att det är intressant att studera vad fungerar i lärar-studentmötet
Forskning
Mitt huvudsakliga forskningsområde är obesitas, mer bestämt medicinsk behandling och samspelet med kost. Jag bedriver även viss undervisning inom obesitasområdet, främst för läkar- och sjuksköterskeprogrammet.

Publikationer
Urval av publikationer
-
Response to review by Pan et al.
Ingår i Obesity, s. 1603-1604, 2024
-
Ingår i Obesity, s. 2222-2232, 2022
- DOI för Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial
- Ladda ner fulltext (pdf) av Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial
-
Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.
Ingår i Clinical Pharmacology in Drug Development, s. 1242-1247, 2021
- DOI för Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.
- Ladda ner fulltext (pdf) av Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.
-
Ingår i Obesity Science & Practice, s. 313-323, 2020
- DOI för Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity
- Ladda ner fulltext (pdf) av Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity
-
Preserved Fat-Free Mass after Gastric Bypass and Duodenal Switch
Ingår i Obesity Surgery, s. 1735-1740, 2017
-
Energy Expenditure And Carbohydrate Oxidation In Responders And Non-Responders After Gastric Bypass
Ingår i Obesity Surgery, 2016
-
Ingår i Journal of the American Medical Directors Association, s. 740-747, 2015
- DOI för Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial
- Ladda ner fulltext (pdf) av Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial
-
Ingår i Diabetes, s. 1860-1869, 2014
-
Ingår i Neuroendocrinology, s. 291-299, 2013
- DOI för Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake
- Ladda ner fulltext (pdf) av Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake
-
Acute Sleep Restriction Reduces Insulin Sensitivity in Adolescent Boys
Ingår i Sleep, s. 1085-1090, 2013
Senaste publikationer
-
Ingår i Scientific Reports, 2026
- DOI för Effect of dietary counseling and dietary fiber on tolerability during weight management with EMP16 and conventional orlistat: a single-blind randomized pilot trial
- Ladda ner fulltext (pdf) av Effect of dietary counseling and dietary fiber on tolerability during weight management with EMP16 and conventional orlistat: a single-blind randomized pilot trial
-
Ingår i Obesity, s. 1855-1864, 2025
- DOI för The Supportive Effect of Acarbose to Orlistat in Weight Management: A Randomized, Double‐Blind, Multiarm Phase 2 Trial
- Ladda ner fulltext (pdf) av The Supportive Effect of Acarbose to Orlistat in Weight Management: A Randomized, Double‐Blind, Multiarm Phase 2 Trial
-
Ingår i Clinical Pharmacology in Drug Development, s. 304-310, 2025
-
Ingår i BMJ Open, 2024
- DOI för Factors associated with changes in walking performance in individuals 3 months after stroke or TIA: secondary analyses from a randomised controlled trial of SMS-delivered training instructions in Sweden
- Ladda ner fulltext (pdf) av Factors associated with changes in walking performance in individuals 3 months after stroke or TIA: secondary analyses from a randomised controlled trial of SMS-delivered training instructions in Sweden
-
Response to review by Pan et al.
Ingår i Obesity, s. 1603-1604, 2024
Alla publikationer
Artiklar i tidskrift
-
Ingår i Scientific Reports, 2026
- DOI för Effect of dietary counseling and dietary fiber on tolerability during weight management with EMP16 and conventional orlistat: a single-blind randomized pilot trial
- Ladda ner fulltext (pdf) av Effect of dietary counseling and dietary fiber on tolerability during weight management with EMP16 and conventional orlistat: a single-blind randomized pilot trial
-
Ingår i Obesity, s. 1855-1864, 2025
- DOI för The Supportive Effect of Acarbose to Orlistat in Weight Management: A Randomized, Double‐Blind, Multiarm Phase 2 Trial
- Ladda ner fulltext (pdf) av The Supportive Effect of Acarbose to Orlistat in Weight Management: A Randomized, Double‐Blind, Multiarm Phase 2 Trial
-
Ingår i Clinical Pharmacology in Drug Development, s. 304-310, 2025
-
Ingår i BMJ Open, 2024
- DOI för Factors associated with changes in walking performance in individuals 3 months after stroke or TIA: secondary analyses from a randomised controlled trial of SMS-delivered training instructions in Sweden
- Ladda ner fulltext (pdf) av Factors associated with changes in walking performance in individuals 3 months after stroke or TIA: secondary analyses from a randomised controlled trial of SMS-delivered training instructions in Sweden
-
Response to review by Pan et al.
Ingår i Obesity, s. 1603-1604, 2024
-
Ingår i Obesity, s. 2222-2232, 2022
- DOI för Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial
- Ladda ner fulltext (pdf) av Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial
-
Ingår i Clinical Rehabilitation, s. 276-287, 2021
- DOI för Effects on walking performance and lower body strength by short message service guided training after stroke or transient ischemic attack (The STROKEWALK Study): a randomized controlled trial
- Ladda ner fulltext (pdf) av Effects on walking performance and lower body strength by short message service guided training after stroke or transient ischemic attack (The STROKEWALK Study): a randomized controlled trial
-
Ingår i BMJ Open, 2021
- DOI för Potential effects on cardiometabolic risk factors and body composition by short message service (SMS)-guided training after recent minor stroke or transient ischaemic attack: post hoc analyses of the STROKEWALK randomised controlled trial
- Ladda ner fulltext (pdf) av Potential effects on cardiometabolic risk factors and body composition by short message service (SMS)-guided training after recent minor stroke or transient ischaemic attack: post hoc analyses of the STROKEWALK randomised controlled trial
-
Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.
Ingår i Clinical Pharmacology in Drug Development, s. 1242-1247, 2021
- DOI för Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.
- Ladda ner fulltext (pdf) av Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.
-
Ingår i Obesity Science & Practice, s. 313-323, 2020
- DOI för Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity
- Ladda ner fulltext (pdf) av Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity
-
Ingår i Preventive Medicine Reports, s. 109-114, 2018
- DOI för Protocol and pilot study of a short message service-guided training after acute stroke/transient ischemic attack to increase walking capacity and physical activity
- Ladda ner fulltext (pdf) av Protocol and pilot study of a short message service-guided training after acute stroke/transient ischemic attack to increase walking capacity and physical activity
-
Ingår i Respiratory Medicine, s. 205-209, 2017
-
Ingår i The FASEB Journal, 2017
-
Preserved Fat-Free Mass after Gastric Bypass and Duodenal Switch
Ingår i Obesity Surgery, s. 1735-1740, 2017
-
Energy Expenditure And Carbohydrate Oxidation In Responders And Non-Responders After Gastric Bypass
Ingår i Obesity Surgery, 2016
-
Children with cerebral palsy do not achieve healthy physical activity levels
Ingår i Acta Paediatrica, s. 1125-1129, 2015
-
Ingår i Journal of the American Medical Directors Association, s. 740-747, 2015
- DOI för Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial
- Ladda ner fulltext (pdf) av Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial
-
Ingår i The FASEB Journal, 2015
-
Ingår i Diabetes, s. 1860-1869, 2014
-
Body composition, energy metabolism and endocrine variables in weight stable gastric-bypass patients
Ingår i The FASEB Journal, 2013
-
Ingår i Neuroendocrinology, s. 291-299, 2013
- DOI för Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake
- Ladda ner fulltext (pdf) av Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake
-
Acute Sleep Restriction Reduces Insulin Sensitivity in Adolescent Boys
Ingår i Sleep, s. 1085-1090, 2013
-
Sleep restriction is not associated with a positive energy balance in adolescent boys
Ingår i American Journal of Clinical Nutrition, s. 240-248, 2012
-
Short sleep duration and its association with energy metabolism
Ingår i Obesity Reviews, s. 565-577, 2012
-
Eating and shift work: effects on habits, metabolism and performance
Ingår i Scandinavian Journal of Work, Environment and Health, s. 150-162, 2010
-
Ingår i European Journal of Endocrinology, s. 383-390, 2010
-
Overweight more prevalent among children than among adolescents
Ingår i Acta Paediatrica, s. 577-581, 2007
-
Ingår i Eur J Appl Physiol, s. 1-7, 2006
-
Effects of acutely displaced sleep on testosterone.
Ingår i J Clin Endocrinol Metab, s. 4530-5, 2005
-
Performance and sleepiness during a 24 h wake in constant conditions are affected by diet.
Ingår i Biol Psychol, s. 251-63, 2004
-
Increased VLDL-TAG turnover during and after acute moderate-intensity exercise.
Ingår i Med Sci Sports Exerc, s. 801-6, 2004
-
Endocrine responses to nocturnal eating - possible implications for nightwork.
Ingår i Eur J Nutr, s. 75, 2003
-
Metabolic responses to nocturnal eating in men are affected by sources of dietary energy
Ingår i Journal of Nutrition, s. 1892-1899, 2002